Yestino - The Signal ยท Grailhttps://yestino.com/entities/grail-b730f9Every event involving GrailenFDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balancehttps://yestino.com/events/fda-advisers-are-voting-on-grail-s-multicancer-blood-test-as-a5bd82https://yestino.com/events/fda-advisers-are-voting-on-grail-s-multicancer-blood-test-as-a5bd82Wed, 23 Sep 2026 13:44:21 GMTThe Molecular and Clinical Genetics Panel is weighing the Galleri test's clinical evidence today; Medicare coverage could follow FDA approval Sources: Quartz